Related Experiment Video
Updated: Aug 5, 2026

06:19
Intracameral Injection in Rats with Low Risk of Adverse Effects
Published on: May 31, 2024
In Vivo Evaluation of Preoperative Topical Strategies in Reducing Conjunctival Microbial Load before Intravitreal
Carlo Cagini1, Nicola De Santi1, Chiara Solito1
1Department of Medicine Surgical, Section of Ophthalmology, S. Maria della Misericordia Hospital, University of Perugia, Perugia, Italy.
Summary
Preoperative topical Polyquaternium-133 eye drops significantly reduced conjunctival bacterial load before intravitreal injections. This antiseptic showed a complementary effect with standard povidone-iodine disinfection, suggesting improved prophylaxis.
Area of Science:
- Ophthalmology
- Microbiology
- Infectious Disease Prevention
Background:
- Intravitreal injections (IVIs) carry a risk of infection due to potential conjunctival microbial contamination.
- Standard preoperative disinfection protocols aim to minimize this risk, but alternative or adjunctive strategies are continuously explored.
Purpose of the Study:
- To evaluate the in vivo efficacy of different topical antiseptic strategies administered before IVIs in reducing conjunctival microbial load.
- To compare these strategies against standard 5% povidone-iodine (PI-5%) preoperative disinfection.
Main Methods:
- A prospective randomized comparative study involving 205 patients scheduled for IVIs.
- Patients received preoperative topical drops of 0.1% Polyquaternium-133, 0.6% povidone-iodine, 0.02% chlorhexidine digluconate, or no drops (control) three times daily for three days.
- Conjunctival swabs were collected at baseline, before standard disinfection, and after PI-5% application to assess microbial load (CFU count).
Main Results:
- 0.1% Polyquaternium-133 significantly reduced conjunctival bacterial load from baseline (T0) to before standard disinfection (T1).
- This reduction was further enhanced when Polyquaternium-133 was used in conjunction with standard PI-5% disinfection.
- While other agents showed limited efficacy, Polyquaternium-133 demonstrated activity against key pathogens like Corynebacterium macginleyi and Staphylococcus aureus.
Conclusions:
- No regimen achieved complete conjunctival sterility.
- 0.1% Polyquaternium-133 offers a significant reduction in conjunctival bacterial load and complements standard PI-5% disinfection.
- These findings suggest a potential clinical benefit of Polyquaternium-133 in the prophylaxis of infections associated with intravitreal injections.
Keywords:
chlorhexidine digluconateconjunctival microbiotaintravitreal injectionpolyquaternium-133povidone-iodinesurgical prophylaxisMore Related Videos
Related Concept Videos
Microbiome of the Eye
The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...

